Timely Rescheduling Of CoSeal Panel Review Expected By Product Sponsor
This article was originally published in The Gray Sheet
Executive Summary
Cohesion Technologies says it anticipates an "expeditious" reconvening of FDA's Circulatory System Devices Panel, which had planned to review the firm's CoSeal surgical sealant product on Sept. 11.